Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy.
Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A.
Galli M, et al. Among authors: pace s.
Haematologica. 2018 Oct;103(10):e469-e472. doi: 10.3324/haematol.2017.182865. Epub 2018 Apr 26.
Haematologica. 2018.
PMID: 29700168
Free PMC article.
Clinical Trial.
No abstract available.